| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Nov―17 |
Changes in biologic treatment patterns for psoriasis before and after the COVID-19 pandemic in Japan; a single center retrospective study |
Natsumi Ikumi, Hideki Fujita |
| 2 |
[GO] |
2023―Oct―03 |
Pityriasis rubra pilaris following administration of SARS-CoV-2 vaccine |
Shumpei Kondo, Yasuaki Ogura, Masaki Ohtsuka, Yoshiki Tokura |
| 3 |
[GO] |
2023―Aug―08 |
A case of disseminated erythematous drug eruption caused by favipiravir in a patient with COVID-19 |
Aki Honda, Toshiyuki Yamamoto |
| 4 |
[GO] |
2023―Jul―17 |
Angioedema-like eyelid edema following the second NVX-CoV2373 COVID-19 vaccination |
Mari Matsumoto, Yoshio Kawakami, Tomoko Miyake, Yoji Hirai, Hitomi Kataoka, Fumio Otsuka, Shin Morizane |
| 5 |
[GO] |
2023―Jun―02 |
Atypical subepidermal blistering disease following COVID-19 vaccination |
Noureddine Litaiem, Azza Ghannem, Amal Chabbouh, Soumaya Rammeh, Maryam Sellami, Faten Zeglaoui |
| 6 |
[GO] |
2023―Apr―21 |
Erythematous reaction of the BCG site to Pfizer-BioNTech COVID-19 vaccine |
Yuta Ito, Marie Suzuki, Marina Seki, Takehiro Okusa, Tokio Nakada |
| 7 |
[GO] |
2023―Jan―16 |
A case of extensive alopecia areata following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine with favorable outcome |
Yoshihiro Matsuda, Yoshio Kawakami, Masaya Kawamoto, Yoji Hirai, Shin Morizane |
| 8 |
[GO] |
2022―May―13 |
Development of Schamberg's disease after
SARS-CoV
-2 vaccination |
Hiroki Morimoto, Yasuaki Ogura, Masaki Otsuka, Satoshi Hayano, Yoshiki Tokura |
| 9 |
[GO] |
2022―Apr―20 |
Development of
IgA
vasculitis after
SARS-CoV
-2 vaccination |
Yasuaki Ogura, Hiroki Morimoto, Masaki Otsuka, Yoshiki Tokura |
| 10 |
[GO] |
2021―Oct―28 |
Unilateral lymphadenopathy associated with COVID-19 vaccination |
Soichiro Kado, Koji Kamiya, Satoshi Iwabuchi, Eiji Kajii, Mamitaro Ohtsuki |
| 11 |
[GO] |
2021―Aug―19 |
Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccination |
Akihiro Matsubara, Mai Sakurai, Akimichi Morita |
| 12 |
[GO] |
2020―Jul―28 |
Reducing immunosuppressant use in patients with chronic inflammation during the COVID-19 pandemic: Risks versus benefits |
Mariko Ogawa-Momohara, Yoshinao Muro, Takuya Takeichi, Masashi Akiyama |
